Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1998-01-05
1999-11-30
Lankford, Jr., Leon B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 3, 514 4, 514 21, 530303, 530306, A61K 3800, A61K 3140
Patent
active
059943033
ABSTRACT:
A combination of insulin and an insulin-like growth factor I (IGF-I) as used in the manufacture of a medicament for counteracting a decrease in nitrogen balance and for counteracting a decrease in protein synthesis. The medicament can be used for the treatment of catabolism which is a protein catabolism due to glucocorticoid excess.
REFERENCES:
patent: 4988675 (1991-01-01), Froesch et al.
patent: 5091173 (1992-02-01), Buultjens et al.
patent: 5128320 (1992-07-01), Hahn et al.
patent: 5434134 (1995-07-01), Gluckman et al.
Arrhenius-Nyberg Vibeke
Malmlof Kjell
Skottner Anna
Blackburn Robert P.
Chiron Corporation
Guth Joseph H.
Lankford , Jr. Leon B.
Spruill W. Murray
LandOfFree
Use of insulin and IGF-I does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of insulin and IGF-I, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of insulin and IGF-I will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1672516